國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Cannabinoids in neurologic and menta...

Fattore, Liana,

Cannabinoids in neurologic and mental disease

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Cannabinoids in neurologic and mental diseaseedited by Liana Fattore.
其他作者:	Fattore, Liana,
出版者:	Amsterdam :Academic Press,2015.
面頁冊數:	1 online resource
標題:	Cannabinoids.
電子資源:	https://www.sciencedirect.com/science/book/9780124170414
ISBN:	9780124171244 (electronic bk.)

Cannabinoids in neurologic and mental disease
Cannabinoids in neurologic and mental disease[electronic resource] /edited by Liana Fattore. - Amsterdam :Academic Press,2015. - 1 online resource

Includes bibliographical references and index.

The application of cannabis sativa for the treatment of neurologic and mental disease is expanding. Cannabinoids in Neurologic and Mental Disease collects and presents for the first time recent research involving the use of pharmacological cannabinoids for the treatment of neurodegenerative and neuroinflammatory disease. The neurologic application of cannabinoid therapy builds upon psychiatric and psychological use for the treatment of a variety of core mental disorders. This comprehensive reference on the known uses of cannabinoids will be useful for clinical neurologists, neuroscience and clinical neuroscience researchers, clinical psychologists and psychiatrists and the general medical community. A comprehensive reference on the clinical uses of cannabinoids for treating major neurologic and mental diseases Detailed coverage of cannabinoid use for neuroinflammatory and neurodegenerative disease including Multiple Sclerosis, Epilepsy, Huntington's disease, Parkinson's disease, and Alzheimer's disease Detailed coverage of cannabinoid use for major psychiatric and psychological diseases and disorders including schizophrenia, bipolar disorders, Tourette's syndrome, and post-traumatic stress disorder (PTSD).

ISBN: 9780124171244 (electronic bk.)Subjects--Topical Terms:

520354
Cannabinoids.
Index Terms--Genre/Form:

214472
Electronic books.

LC Class. No.: RM666.C266

Dewey Class. No.: 615.7/827

National Library of Medicine Call No.: WL 140

Cannabinoids in neurologic and mental disease
LDR:02342nmm a2200265 a 4500 001 578370
006 m o d
007 cr cnu|unuuu||
008 201211s2015 ne ob 001 0 eng d
020 $a 9780124171244 (electronic bk.)
020 $a 0124171249 (electronic bk.)
020 $a 9780124170414
035 $a (OCoLC)900781293
035 $a ELS20100004
040 $a N $b eng $c N $d N $d IDEBK $d UIU $d OPELS $d EBLCP $d OCLCF $d CDX $d DEBSZ $d YDXCP $d ABH $d FEM $d VGM $d OCLCO $d MERER $d OCLCO $d OCLCQ $d YDX $d OCLCO $d OCLCA $d MERUC $d OCLCO $d OCLCA $d UUM $d DEBBG $d U3W $d OCLCO $d D6H $d AU@ $d OCLCO $d OCLCQ $d OCLCO $d OCLCQ $d OCLCO $d UKMGB $d OCLCQ $d OCLCO $d OCLCA
041 0 $a eng
050 4 $a RM666.C266
060 4 $a WL 140
082 0 4 $a 615.7/827 $2 23
245 0 0 $a Cannabinoids in neurologic and mental disease $h [electronic resource] / $c edited by Liana Fattore.
260 $a Amsterdam : $b Academic Press, $c 2015.
300 $a 1 online resource
504 $a Includes bibliographical references and index.
520 $a The application of cannabis sativa for the treatment of neurologic and mental disease is expanding. Cannabinoids in Neurologic and Mental Disease collects and presents for the first time recent research involving the use of pharmacological cannabinoids for the treatment of neurodegenerative and neuroinflammatory disease. The neurologic application of cannabinoid therapy builds upon psychiatric and psychological use for the treatment of a variety of core mental disorders. This comprehensive reference on the known uses of cannabinoids will be useful for clinical neurologists, neuroscience and clinical neuroscience researchers, clinical psychologists and psychiatrists and the general medical community. A comprehensive reference on the clinical uses of cannabinoids for treating major neurologic and mental diseases Detailed coverage of cannabinoid use for neuroinflammatory and neurodegenerative disease including Multiple Sclerosis, Epilepsy, Huntington's disease, Parkinson's disease, and Alzheimer's disease Detailed coverage of cannabinoid use for major psychiatric and psychological diseases and disorders including schizophrenia, bipolar disorders, Tourette's syndrome, and post-traumatic stress disorder (PTSD).
588 0 $a Online resource; title from PDF title page (ScienceDirect, viewed February 16, 2015).
650 0 $a Cannabinoids. $3 520354
650 0 $a Mental illness $x Alternative treatment. $3 458394
650 1 2 $a Nervous System Diseases $x drug therapy. $3 229904
650 1 2 $a Cannabinoids $x therapeutic use. $3 717602
650 2 2 $a Mental Disorders $x drug therapy. $3 374279
655 4 $a Electronic books. $2 local. $3 214472
700 1 $a Fattore, Liana, $e editor. $3 867105
856 4 0 $u https://www.sciencedirect.com/science/book/9780124170414